Moore Capital Management’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
Moore Capital Management's FLGT Position: Q3 2026 in Review
Moore Capital Management reduced its Fulgent Genetics (FLGT) stake by 8.2% in Q3 2026, selling an estimated $79.4K and leaving 44,390 shares worth $977K. The position accounts for 0.02% of the portfolio, ranked #425.
Moore Capital Management first reported a position in FLGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $992K in Q2 2026. 142 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.
- Moore Capital Management held 44,390 shares of Fulgent Genetics worth $977K as of Q3 2026.
- Moore Capital Management sold 3,953 Fulgent Genetics shares in Q3 2026, an estimated $79.4K.
- Fulgent Genetics made up 0.02% of Moore Capital Management's portfolio in Q3 2026, its #425 holding.
- Moore Capital Management first reported a position in Fulgent Genetics in Q1 2026 and has held it in 3 quarters since.
- Moore Capital Management's Fulgent Genetics position peaked at $992K in Q2 2026.
- 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.
Based on Moore Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.